Regulatory functions of B cells and regulatory plasma cells.


Journal

Biomedical journal
ISSN: 2320-2890
Titre abrégé: Biomed J
Pays: United States
ID NLM: 101599820

Informations de publication

Date de publication:
08 2019
Historique:
received: 14 03 2019
accepted: 22 05 2019
entrez: 20 10 2019
pubmed: 20 10 2019
medline: 15 4 2020
Statut: ppublish

Résumé

B cells critically contribute to health through the production of antibodies that provide a vital line of defence against infectious agents. In addition, B cells are known to play an integrative role in immunity, acting as crucial antigen-presenting cells for T cells, and being an important source of cytokines that can target multiple cell types including stromal cells, innate cells, and adaptive lymphocytes. This review focuses on the role of B cells as negative regulators of immunity through the production of interleukin-10 (IL-10) in autoimmune, infectious, and malignant diseases. It discusses the phenotypes of the B cell subsets most competent to produce IL-10 in vitro and to exert suppressive functions in vivo upon adoptive transfer in recipient mice, the signals and transcription factors regulating IL-10 expression in B cells, and the recent identification of plasmocytes, including short-lived plasmablasts and long-lived plasma cells, as an important source of IL-10 in secondary lymphoid organs and inflamed tissues in vivo during mouse and human diseases. With our increasing knowledge of this non-canonical B cell function a coherent framework starts emerging that will help monitoring and targeting this B cell function in health and disease.

Identifiants

pubmed: 31627865
pii: S2319-4170(19)30197-0
doi: 10.1016/j.bj.2019.05.008
pmc: PMC6818159
pii:
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

233-242

Informations de copyright

Copyright © 2019 Chang Gung University. Published by Elsevier B.V. All rights reserved.

Références

Cell. 2019 Jan 24;176(3):610-624.e18
pubmed: 30612739
Brain. 2018 Jul 1;141(7):2066-2082
pubmed: 29873694
J Autoimmun. 1994 Aug;7(4):425-39
pubmed: 7980846
Eur J Immunol. 2017 Mar;47(3):493-503
pubmed: 28012163
Nat Rev Immunol. 2015 Jul;15(7):441-51
pubmed: 26065586
J Allergy Clin Immunol. 2016 Jan;137(1):157-167
pubmed: 26152318
Crit Rev Biochem Mol Biol. 2014 Jan-Feb;49(1):1-15
pubmed: 24099156
Immunity. 2002 Feb;16(2):219-30
pubmed: 11869683
Autoimmunity. 1994;18(1):51-6
pubmed: 7999955
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13938-43
pubmed: 10570177
Nature. 2017 Nov 16;551(7680):340-345
pubmed: 29144460
Immunol Rev. 2010 Sep;237(1):117-39
pubmed: 20727033
Eur J Immunol. 2014 Jun;44(6):1615-21
pubmed: 24643722
J Virol. 2007 Sep;81(17):9357-67
pubmed: 17567692
Am J Pathol. 2011 Feb;178(2):735-43
pubmed: 21281806
J Immunol. 2009 Mar 15;182(6):3492-3502
pubmed: 19265127
Arthritis Res Ther. 2017 Jan 19;19(1):8
pubmed: 28103916
PLoS Pathog. 2008 Apr 04;4(4):e1000039
pubmed: 18389062
Curr Opin Immunol. 2001 Apr;13(2):195-201
pubmed: 11228413
J Autoimmun. 2002 Mar;18(2):181-90
pubmed: 11908950
Thromb Haemost. 1997 May;77(5):856-61
pubmed: 9184392
Eur J Immunol. 2007 Sep;37(9):2405-10
pubmed: 17683117
Immunity. 2010 Nov 24;33(5):777-90
pubmed: 21093317
Immunol Today. 1991 May;12(5):154-9
pubmed: 1715166
J Exp Med. 1996 Dec 1;184(6):2271-8
pubmed: 8976182
Semin Arthritis Rheum. 1990 Feb;19(4):224-42
pubmed: 2181670
J Clin Invest. 2008 Oct;118(10):3420-30
pubmed: 18802481
J Exp Med. 2011 Apr 11;208(4):823-39
pubmed: 21464221
J Exp Med. 1997 Nov 17;186(10):1749-56
pubmed: 9362534
Immunity. 2010 Jan 29;32(1):129-40
pubmed: 20079667
Nature. 2015 May 7;521(7550):94-8
pubmed: 25924065
Springer Semin Immunopathol. 2004 Feb;25(3-4):335-48
pubmed: 15007635
J Immunol. 2007 Jul 1;179(1):154-61
pubmed: 17579033
Immunol Rev. 2010 Jan;233(1):146-61
pubmed: 20192998
Immunity. 2007 Mar;26(3):299-310
pubmed: 17363299
J Immunol. 2008 Apr 1;180(7):4763-73
pubmed: 18354200
Br J Cancer. 2014 May 13;110(10):2472-8
pubmed: 24736579
Annu Rev Immunol. 2013;31:51-72
pubmed: 23157435
Nat Commun. 2016 May 25;7:11724
pubmed: 27222343
Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12105-10
pubmed: 22773818
J Immunol. 2014 May 15;192(10):4852-8
pubmed: 24740500
Immunity. 2014 Dec 18;41(6):1040-51
pubmed: 25484301
J Clin Invest. 2011 Sep;121(9):3645-56
pubmed: 21821911
Immunity. 2007 Dec;27(6):927-40
pubmed: 18082433
Eur J Immunol. 1999 Oct;29(10):3285-94
pubmed: 10540340
J Autoimmun. 2014 May;50:107-22
pubmed: 24491821
Front Immunol. 2018 Dec 21;9:3034
pubmed: 30622536
J Exp Med. 2003 Feb 17;197(4):489-501
pubmed: 12591906
Immunity. 2018 Aug 21;49(2):264-274.e4
pubmed: 30076099
J Med Microbiol. 1998 Jan;47(1):49-54
pubmed: 9449949
Nature. 2012 Nov 8;491(7423):264-8
pubmed: 23064231
J Immunol. 2005 Sep 1;175(5):2925-30
pubmed: 16116178
PLoS Pathog. 2014 Jan;10(1):e1003858
pubmed: 24391506
Nature. 2014 Mar 20;507(7492):366-370
pubmed: 24572363
J Exp Med. 1994 Apr 1;179(4):1317-30
pubmed: 7511686
Cell Rep. 2015 Nov 10;13(6):1110-1117
pubmed: 26527007
Nat Med. 2014 Nov;20(11):1334-9
pubmed: 25326801
Nat Med. 2013 Jun;19(6):739-46
pubmed: 23624599
Nat Commun. 2018 Jan 17;9(1):251
pubmed: 29343683
Immunol Rev. 2010 May;235(1):172-89
pubmed: 20536563
Immunity. 2018 Jul 17;49(1):120-133.e9
pubmed: 30005826
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4542-6
pubmed: 17360560
Immunity. 2007 Dec;27(6):941-51
pubmed: 18083575
J Immunol. 2002 Jun 1;168(11):5605-11
pubmed: 12023357
Cell. 2005 Oct 21;123(2):321-34
pubmed: 16239148
Oncogene. 2019 Apr;38(17):3316-3324
pubmed: 30635655
Acta Neuropathol Commun. 2017 Nov 25;5(1):88
pubmed: 29178933
Mol Immunol. 2009 Feb;46(4):613-21
pubmed: 18962896
Immunity. 2011 May 27;34(5):703-14
pubmed: 21530328
Cancer Cell. 2014 Sep 8;26(3):331-343
pubmed: 25132496
Expert Rev Clin Immunol. 2007 Jul;3(4):565-78
pubmed: 20477161
J Immunol. 2007 Mar 15;178(6):3593-601
pubmed: 17339456
Trends Immunol. 2006 Oct;27(10):461-9
pubmed: 16931157
J Exp Med. 2012 May 7;209(5):1001-10
pubmed: 22547654
Nat Immunol. 2002 Oct;3(10):944-50
pubmed: 12244307
Immunity. 2005 Apr;22(4):467-77
pubmed: 15845451
Eur J Immunol. 1997 Sep;27(9):2366-74
pubmed: 9341782
Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):E5434-43
pubmed: 27578867
Clin Transl Allergy. 2016 May 25;6:19
pubmed: 27231527
J Immunol. 2010 May 1;184(9):4637-45
pubmed: 20335532
Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):9021-6
pubmed: 19439663
J Immunol. 2013 Sep 1;191(5):2780-2795
pubmed: 23918988
J Exp Med. 1995 Nov 1;182(5):1597-601
pubmed: 7595231
J Autoimmun. 1990 Dec;3(6):773-87
pubmed: 2088393
J Clin Invest. 2000 Jun;105(12):1731-40
pubmed: 10862788
J Immunol. 2007 Jun 15;178(12):7868-78
pubmed: 17548625
Immunity. 2008 May;28(5):639-50
pubmed: 18482568
Eur J Immunol. 2011 Jun;41(6):1696-708
pubmed: 21469107
J Immunol. 2015 Feb 15;194(4):1602-8
pubmed: 25582854
J Leukoc Biol. 2005 Jun;77(6):948-57
pubmed: 15772125
Front Immunol. 2018 Jan 19;8:1951
pubmed: 29403470

Auteurs

Simon Fillatreau (S)

Institut Necker-Enfants Malades (INEM), INSERM U1151-CNRS UMR 8253, Paris, France; Faculty of Medicine, Paris Descartes University, Paris-Sorbonne University, Paris, France; AP-HP Necker-Enfants Malades Hospital, Paris, France. Electronic address: simonfillatreau@googlemail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH